INTRODUCTION: The Centers for Disease Control and Prevention (CDC) advise repeat HIV testing for partners of HIV-infected persons; injection drug users and their sex partners; individuals with recent multiple partnerships and their sex partners; those involved in sex trade; and men who have sex with men. Additional social and behavioral variables may be useful for identifying priority populations. METHODS: We analyzed data collected during a social network study conducted in a Brooklyn, NY, neighborhood to identify social and behavioral characteristics of respondents (N = 343) involved in HIV-discordant, herpes simplex virus-2- discordant, and chlamydia-discordant partnerships. RESULTS: HIV partnership discordance was associated with injection drug use but was generally not associated with sexual behaviors including multiple partnerships and sex trade. herpes simplex virus-2 and chlamydia partnership discordance were associated with multiple partnerships, sex trade, and same sex partnership history. Additional correlates of sexually transmitted infection (STI)/HIV-discordant partnerships included older age (>or=25 years), noninjection drug use, and incarceration history. Analyses suggested that screening tools composed of CDC-recommended sexual risk and injection drug indicators plus indicators of older age, noninjection drug use, and incarceration were more effective in identifying STI/HIV priority populations than tools composed of CDC indicators alone. CONCLUSIONS: Screening tools that include social and behavioral indicators may improve STI/HIV case-finding effectiveness.
INTRODUCTION: The Centers for Disease Control and Prevention (CDC) advise repeat HIV testing for partners of HIV-infectedpersons; injection drug users and their sex partners; individuals with recent multiple partnerships and their sex partners; those involved in sex trade; and men who have sex with men. Additional social and behavioral variables may be useful for identifying priority populations. METHODS: We analyzed data collected during a social network study conducted in a Brooklyn, NY, neighborhood to identify social and behavioral characteristics of respondents (N = 343) involved in HIV-discordant, herpes simplex virus-2- discordant, and chlamydia-discordant partnerships. RESULTS: HIV partnership discordance was associated with injection drug use but was generally not associated with sexual behaviors including multiple partnerships and sex trade. herpes simplex virus-2 and chlamydia partnership discordance were associated with multiple partnerships, sex trade, and same sex partnership history. Additional correlates of sexually transmitted infection (STI)/HIV-discordant partnerships included older age (>or=25 years), noninjection drug use, and incarceration history. Analyses suggested that screening tools composed of CDC-recommended sexual risk and injection drug indicators plus indicators of older age, noninjection drug use, and incarceration were more effective in identifying STI/HIV priority populations than tools composed of CDC indicators alone. CONCLUSIONS: Screening tools that include social and behavioral indicators may improve STI/HIV case-finding effectiveness.
Authors: A David Paltiel; Rochelle P Walensky; Bruce R Schackman; George R Seage; Lauren M Mercincavage; Milton C Weinstein; Kenneth A Freedberg Journal: Ann Intern Med Date: 2006-12-05 Impact factor: 25.391
Authors: Samuel R Friedman; Melissa Bolyard; Pedro Mateu-Gelabert; Paula Goltzman; Maria Pia Pawlowicz; Dhan Zunino Singh; Graciela Touze; Diana Rossi; Carey Maslow; Milagros Sandoval; Peter L Flom Journal: AIDS Behav Date: 2007-09
Authors: Fujie Xu; Maya R Sternberg; Benny J Kottiri; Geraldine M McQuillan; Francis K Lee; Andre J Nahmias; Stuart M Berman; Lauri E Markowitz Journal: JAMA Date: 2006-08-23 Impact factor: 56.272
Authors: Cheryl R Stein; Jay S Kaufman; Carol A Ford; Paul J Feldblum; Peter A Leone; William C Miller Journal: Sex Transm Dis Date: 2008-05 Impact factor: 2.830
Authors: Don C Des Jarlais; Holly Hagan; Kamyar Arasteh; Courtney McKnight; David Perlman; Samuel R Friedman Journal: Sex Transm Dis Date: 2007-11 Impact factor: 2.830
Authors: Jacky M Jennings; Sarah Polk; Caroline Fichtenberg; Shang-en Chung; Jonathan M Ellen Journal: Ann Epidemiol Date: 2015-07-30 Impact factor: 3.797
Authors: Typhanye V Dyer; Maria R Khan; Milagros Sandoval; Abenaa Acheampong; Rotrease Regan; Melissa Bolyard; Pedro Mateu-Gelabert; Samuel R Friedman Journal: AIDS Behav Date: 2017-12
Authors: Susan M Rogers; Maria R Khan; Sylvia Tan; Charles F Turner; William C Miller; Emily Erbelding Journal: Sex Transm Infect Date: 2012-02 Impact factor: 3.519
Authors: Brandon D L Marshall; Magdalena M Paczkowski; Lars Seemann; Barbara Tempalski; Enrique R Pouget; Sandro Galea; Samuel R Friedman Journal: PLoS One Date: 2012-09-13 Impact factor: 3.240
Authors: Joy D Scheidell; Typhanye V Dyer; Andrea K Knittel; Ellen C Caniglia; Lorna E Thorpe; Andrea B Troxel; Carl W Lejuez; Maria R Khan Journal: J Womens Health (Larchmt) Date: 2021-05-28 Impact factor: 3.017